These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6188984)

  • 1. Does bromocriptine have a cytocidal effect on prolactinoma cells? Report of a case.
    Gen M; Uozumi T; Shinohara S; Naito M; Ito A; Mori S; Kajiwara H
    Neurol Med Chir (Tokyo); 1983 Jan; 23(1):61-5. PubMed ID: 6188984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 3. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES; García IC; Ruíz JE; Zárate A
    Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
    Ayers JW
    Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
    Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
    Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
    Ayalon D; Eckstein N; Homonnai ZT; Paz GF; Eshel A; Reider I
    Int J Gynaecol Obstet; 1982 Dec; 20(6):481-5. PubMed ID: 6130996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.
    Saunders NJ
    Postgrad Med J; 1985 Sep; 61(719):829-30. PubMed ID: 4059146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
    Fagel WJ; Hekster RE; Smith SJ; van der Vijver JC
    Neuroradiology; 1986; 28(4):364-6. PubMed ID: 3762918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports.
    Crosignani P; Ferrari C; Mattei AM
    Br J Obstet Gynaecol; 1984 Aug; 91(8):821-3. PubMed ID: 6466586
    [No Abstract]   [Full Text] [Related]  

  • 12. The medical treatment of prolactin and growth hormone-secreting pituitary tumours.
    Lancranjan I
    Acta Neurochir Suppl (Wien); 1990; 47():71-85. PubMed ID: 1968311
    [No Abstract]   [Full Text] [Related]  

  • 13. Size reduction of a large prolactinoma by bromocriptine treatment. Report of a case.
    Matsumura S; Mori S; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):127-30. PubMed ID: 6168944
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual function in prolactinoma patients treated with bromocriptine.
    Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
    Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromocriptine and pituitary tumours.
    Verde G; Chiodini PG; Liuzzi A; Favales F; Cozzi R
    Lancet; 1979 Sep; 2(8142):582. PubMed ID: 89580
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective bromocriptine therapy for large, calcified prolactinoma--pathogenesis of calcifications.
    Inoue H; Kazuno T; Suzuki M; Ishiyama N; Nakamura T; Takenaka N; Otani M; Shinozaki T; Toya S
    Neurol Med Chir (Tokyo); 1986 Jan; 26(1):26-9. PubMed ID: 2425272
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
    Kok JG; Bartelink AK; Schulte BP; Smals A; Pieters G; Meyer E; Merx H
    Neurology; 1985 Aug; 35(8):1193-5. PubMed ID: 4022353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
    Landolt AM; Keller PJ; Froesch ER; Mueller J
    Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789
    [No Abstract]   [Full Text] [Related]  

  • 20. Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.
    King LW; Molitch ME; Gittinger JW; Wolpert SM; Stern J
    Surg Neurol; 1983 Mar; 19(3):280-4. PubMed ID: 6836484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.